GRAIL, Inc.

NASDAQ:GRAL

Medical - Diagnostics & Research

Healthcare
$102.10 +3.20%

+$1.90 today

Market cap
$4.59B
Beta
3.16
P/E (TTM)
-6.3
EPS (TTM)
-$9.73
52W Low $29.95High $118.84

Volume 0.62M

Average 0.77M

GRAL Pre-Tax Margin

Income before tax as a percentage of revenue.

GRAIL, Inc.NASDAQ: GRAL

Pre-Tax Margin · Q2 FY2026 · quarter ended Jun 2026

Pre-tax margin widens to -373.1%

Pre-tax margin was -373.1% in Q2 FY2026, up 57.0 pp from a year earlier. On a trailing-twelve-month basis it was -320.4%, up 125.4 pp year over year. Over 3 fiscal years it widened by 9432.3 pp.

Context

  • Pre-tax margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
-373.1%-60.4 pp QoQ
Last fiscal yearDec 2025
-363.2%+1358.5 pp YoY
LTMJun 2026
-320.4%+125.4 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+57.0 pp——
1 year+1358.5 pp——
3 years+9432.3 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
-363.2%
Year-over-year change
+1358.5pp

Pre-Tax Margin vs competitors

How GRAL compares with its peers on the latest reported figures

  • GRAL's LTM Jun 2026 pre-tax margin of -320.4% is the lowest of the 10 companies compared; the peer median is -23.4%.
  • Its year-over-year change of +125.4 pp is the highest of 10, against a peer median of -4.6 pp.
  • Over three fiscal years its change of +9432.3 pp compares with a peer median of +41.7 pp.
GRAL Competitors Peer median
Pre-Tax Margin for GRAL and competitors
Company Period LTM level YoY 3-year change
BLLNBillionToOne, Inc.LTM Jun 20269.5% +24.1 pp—
CSTLCastle Biosciences, Inc.LTM Mar 2026-5.2% -4.6 pp+41.7 pp
NEONeoGenomics, Inc.LTM Jun 2026-7.1% +8.2 pp+16.1 pp
NTRANatera, Inc.LTM Jun 2026-9.3% +3.6 pp+55.0 pp
WGSGeneDx Holdings Corp.LTM Jun 2026-23.4% -23.8 pp+249.9 pp
FLGTFulgent Genetics, Inc.LTM Mar 2026-25.9% -9.0 pp-51.4 pp
GHGuardant Health, Inc.LTM Sep 2026-38.0% +6.1 pp+102.8 pp
MYGNMyriad Genetics, Inc.LTM Mar 2026-48.2% -33.0 pp-27.2 pp
PSNLPersonalis, Inc.LTM Mar 2026-148.1% -50.0 pp—
GRALGRAIL, Inc.LTM Jun 2026-320.4% +125.4 pp+9432.3 pp
Peer median (excluding GRAL) -23.4%-4.6 pp+41.7 pp

Competitors are the stored peer set for GRAL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue14.61M55.55M93.11M125.6M147.17M
Cost of Revenue114.62M172M188.72M203.62M209.75M
Gross Profit(100M)(116.45M)(95.61M)(78.02M)(62.57M)
Gross Margin-684.4%-209.6%-102.7%-62.1%-42.5%
Research & Development460.21M329.58M338.75M322.38M195.79M
Selling, General & Admin234.06M296.44M362.56M367.82M275.8M
Operating Expenses1.17B5.33B1.42B2.11B471.59M
Depreciation & Amortization58.45M154.76M158.7M158.06M156.34M
EBITDA(1.21B)(587.7M)(638.22M)(610.17M)(378.16M)
EBITDA Margin-8259.0%-1058.0%-685.5%-485.8%-257.0%
Operating Income(1.27B)(5.44B)(1.52B)(2.19B)(534.16M)
Operating Margin-8659.6%-9798.2%-1627.6%-1743.0%-363.0%
Interest Income332K1.74M7.95M26.73M28.65M
Interest Expense00000
Other Income / Expenses90K1.5M7.75M26.8M(341K)
Income Before Tax(1.27B)(5.44B)(1.51B)(2.16B)(534.5M)
Pre-Tax Margin-8659.0%-9795.5%-1619.3%-1721.7%-363.2%
Income Tax Expense(17.48M)(42.29M)(41.95M)(135.36M)(126.15M)
Net Income(1.25B)(5.4B)(1.47B)(2.03B)(408.35M)
Net Margin-8539.4%-9719.3%-1574.2%-1613.9%-277.5%
EPS (Basic)(40.18)(173.87)(47.20)(63.54)(11.11)
EPS (Diluted)(40.18)(173.87)(47.20)(63.54)(11.11)
Weighted Avg Shares31.05M31.05M31.05M31.9M36.75M
Weighted Avg Shares (Diluted)31.05M31.05M31.05M31.9M36.75M

GRAIL, Inc.

NASDAQ:GRAL

Intrinsic Alpha fair value

Locked

Current Price

$102.10

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.